Nationwide Recall of Clonazepam Due to Life-Threatening Labeling Error
TL;DR Summary
The FDA has announced a recall of certain clonazepam medications due to incorrect dosage information on their labels, which could pose safety risks to patients.
- Some Clonazepam Pills Recalled Over Incorrect Doses on Label, F.D.A. Says The New York Times
- Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error Fox News
- Nationwide Recall of Anxiety Drug Over Life-Threatening Packaging Error Newsweek
- Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling PR Newswire
- Popular anxiety drug clonazepam recalled for labeling error ABC News
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
14%
29 → 25 words
Want the full story? Read the original article
Read on The New York Times